Improvement in inducible ischemia during dobutamine stress echocardiography after transmyocardial laser revascularization in patients with refractory angina pectoris
CL Donovan,
KP Landolfo,
JE Lowe,
F Clements,
RB Coleman,
and
T Ryan
Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. donov001@mc.duke.edu
OBJECTIVES: The purpose of this ongoing study is to determine whether transmyocardial laser revascularization (TMLR) can lessen inducible ischemia and improve contractile reserve in patients with refractory angina pectoris. BACKGROUND: TMLR is an emerging surgical technique for the treatment of myocardial ischemia and angina pectoris not amenable to conventional percutaneous or surgical revascularization. Objective data documentating a reduction in ischemia during noninvasive stress testing after TMLR are rare. METHODS: Fifteen patients with severe coronary artery disease unsuitable for treatment with standard revascularization techniques were studied with dobutamine stress echocardiography (DSE) before TMLR. Of the 12 patients who underwent TMLR, DSE was repeated at 3 months postoperatively in 11 patients and at 6 months in 9 patients. Stress echocardiograms were analyzed for inducible ischemia, with calculation of the wall motion score index (WMSI). Heart rate and dobutamine dose achieved at peak stress were also assessed as indexes of stress tolerance. RESULTS: Compared with that before TMLR, wall motion at rest for all myocardial segments did not change significantly after TMLR, although there was a mild improvement in the WMSI of the lased myocardial regions ([mean +/- SD] 1.64 +/- 0.34 after vs. 1.78 +/- 0.34 before TMLR, p < 0.05). Overall WMSI at peak stress improved markedly after TMLR (1.70 +/- 0.30 after vs. 2.06 +/- 0.31 before TMLR, p < 0.002), with the improvement in WMSI limited to the lased segments only (1.47 +/- 0.31 after vs. 2.15 +/- 0.34 before TMLR, p < 0.0004). The improvement in WMSI with stress resulted primarily from a decrease in the percentage of ischemic segments (47% before vs. 23% after TMLR, p < 0.0008), with no change in the percentage of infarcted segments (23% before vs. 26% after TMLR). Heart rate (83 +/- 5 beats/min before vs. 102 +/- 21 beats/min after TMLR, p = 0.01) and dobutamine infusion rate (26 +/- 9 micrograms/kg body weight per min before vs. 34 +/- 9 micrograms/kg per min after TMLR) achieved at peak stress also increased postoperatively, consistent with improved stress tolerance. The reduction in ischemic wall motion abnormalities and improved stress tolerance persisted at 6 months, without evidence of further improvement or deterioration of function over time. CONCLUSIONS: TMLR performed in patients with refractory angina pectoris reduces ischemic wall motion abnormalities and improves stress-induced tolerance during dobutamine echocardiography. These beneficial effects persist up to 6 months postoperatively.
This article has been cited by other articles:

|
 |

|
 |
 
K. A. Horvath and Y. Zhou
Transmyocardial Laser Revascularization and Extravascular Angiogenetic Techniques to Increase Myocardial Blood Flow
Card. Surg. Adult,
January 1, 2008;
3(2008):
733 - 752.
[Full Text]
|
 |
|

|
 |

|
 |
 
S. K. Mouli, J. Fronza, R. Greene, E. S. Robert, and K. A. Horvath
What is the Optimal Channel Density for Transmyocardial Laser Revascularization?
Ann. Thorac. Surg.,
October 1, 2004;
78(4):
1326 - 1331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. M. Muhling, Y. Wang, M. Jerosch-Herold, M. M. Cayton, L. S. Wann, M. M. Mirhoseini, and N. M. Wilke
Improved myocardial function after transmyocardial laser revascularization according to cine magnetic resonance in a porcine model
J. Thorac. Cardiovasc. Surg.,
September 1, 2004;
128(3):
391 - 395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Bridges, K. A. Horvath, W. C. Nugent, D. M. Shahian, C. K. Haan, R. J. Shemin, K. B. Allen, and F. H. Edwards
The Society of Thoracic Surgeons practice guideline series: transmyocardial laser revascularization
Ann. Thorac. Surg.,
April 1, 2004;
77(4):
1494 - 1502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Horvath
Shedding light on denervation and transmyocardial laser revascularization
J. Thorac. Cardiovasc. Surg.,
March 1, 2003;
125(90030):
S74 - 75.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Saririan and M. J. Eisenberg
Myocardial laser revascularization for the treatment of end-stage coronary artery disease
J. Am. Coll. Cardiol.,
January 15, 2003;
41(2):
173 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ruel, R. A. Kelly, and F. W. Sellke
Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy
Card. Surg. Adult,
January 1, 2003;
2(2003):
715 - 750.
[Full Text]
|
 |
|

|
 |

|
 |
 
G. C. Hughes, S. S. Biswas, B. Yin, D. V. Baklanov, B. H. Annex, R. E. Coleman, T. R. DeGrado, C. K. Landolfo, K. P. Landolfo, and J. E. Lowe
A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium
J. Am. Coll. Cardiol.,
April 3, 2002;
39(7):
1220 - 1228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Horvath, N. Belkind, I. Wu, R. Greene, J. Doukas, J. W. Lomasney, D. D. McPherson, and D. A. Fullerton
Functional comparison of transmyocardial revascularization by mechanical and laser means
Ann. Thorac. Surg.,
December 1, 2001;
72(6):
1997 - 2002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Horvath
Shedding light on denervation and transmyocardial laser revascularization
J. Thorac. Cardiovasc. Surg.,
October 1, 2001;
122(4):
647 - 648.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Horvath, S. F. Aranki, L. H. Cohn, R. J. March, O. H. Frazier, K. A. Kadipasaoglu, S. W. Boyce, B. W. Lytle, K. P. Landolfo, J. E. Lowe, et al.
Sustained Angina Relief 5 Years After Transmyocardial Laser Revascularization With a CO2 Laser
Circulation,
September 18, 2001;
104(2009):
I-81 - I-84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. Hughes, C. K. Landolfo, B. Yin, T. R. DeGrado, R. E. Coleman, K. P. Landolfo, and J. E. Lowe
Is chronically dysfunctional yet viable myocardium distal to a severe coronary stenosis hypoperfused?
Ann. Thorac. Surg.,
July 1, 2001;
72(1):
163 - 168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X M Mueller, H T Tevaearai, P Chaubert, C-Y Genton, and L K von Segesser
Does laser injury induce a different neovascularisation pattern from mechanical or ischaemic injuries?
Heart,
June 1, 2001;
85(6):
697 - 701.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Fuchs and R. Kornowski
Transepicardial or transendocardial injury: controversies regarding angiogenic potential and mechanism of action
Cardiovasc Res,
February 16, 2001;
49(3):
582 - 587.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hattan, K. Ban, E. Tanaka, S. Abe, T. Sekka, Y. Sugio, M. U. Mohammed, E. Sato, Y. Shinozai, Y. Onishi, et al.
Transmyocardial revascularization aggravates myocardial ischemia around the channels in the immediate phase
Am J Physiol Heart Circ Physiol,
September 1, 2000;
279(3):
H1392 - H1396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Y. Lee, M. F. O'Hara, E. B. Finnin, R. Hachamovitch, M. Szulc, P. D. Kligfield, P. M. Okin, O. W. Isom, and T. K. Rosengart
Transmyocardial laser revascularization with excimer laser: clinical results at 1 year
Ann. Thorac. Surg.,
August 1, 2000;
70(2):
498 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. Hughes, A. P. Kypson, B. H. Annex, B. Yin, J. D. St. Louis, S. S. Biswas, R. E. Coleman, T. R. DeGrado, C. L. Donovan, K. P. Landolfo, et al.
Induction of angiogenesis after TMR: a comparison of holmium:YAG, CO2, and excimer lasers
Ann. Thorac. Surg.,
August 1, 2000;
70(2):
504 - 509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Martin, U. Sayeed-Shah, J. G. Byrne, M. H.D. Danton, K. Q. Flores, R. G. Laurence, and L. H. Cohn
Excimer versus carbon dioxide transmyocardial laser revascularization: effects on regional left ventricular function and perfusion
Ann. Thorac. Surg.,
June 1, 2000;
69(6):
1811 - 1816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Aaberge, K. Nordstrand, M. Dragsund, K. Saatvedt, K. Endresen, S. Golf, O. Geiran, M. Abdelnoor, and K. Forfang
Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris: Clinical results from The Norwegian Randomized Trial
J. Am. Coll. Cardiol.,
April 1, 2000;
35(5):
1170 - 1177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Bridges
Myocardial laser revascularization: the controversy and the data
Ann. Thorac. Surg.,
February 1, 2000;
69(2):
655 - 662.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lauer, U. Junghans, F. Stahl, R. Kluge, S. N. Oesterle, and G. Schuler
Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease
J. Am. Coll. Cardiol.,
November 15, 1999;
34(6):
1663 - 1670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Landolfo, K. P. Landolfo, G. C. Hughes, E. R. Coleman, R. B. Coleman, and J. E. Lowe
Intermediate-Term Clinical Outcome Following Transmyocardial Laser Revascularization in Patients With Refractory Angina Pectoris
Circulation,
November 9, 1999;
100(90002):
II-128 - II-133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.C. Hughes, B. H. Annex, B. Yin, A. M. Pippen, P. Lin, A. P. Kypson, K. G. Peters, J. E. Lowe, and K. P. Landolfo
Transmyocardial laser revascularization limits in vivo adenoviral-mediated gene transfer in porcine myocardium
Cardiovasc Res,
October 1, 1999;
44(1):
81 - 90.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. M. Mueller, H. T. Tevaearai, C.-Y. Genton, P. Chaubert, and L. K. von Segesser
Are there vascular density gradients along myocardial laser channels?
Ann. Thorac. Surg.,
July 1, 1999;
68(1):
125 - 129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. Hughes, A. P. Kypson, J. D. St. Louis, B. H. Annex, R. E. Coleman, T. R. DeGrado, C. L. Donovan, J. E. Lowe, and K. P. Landolfo
Improved perfusion and contractile reserve after transmyocardial laser revascularization in a model of hibernating myocardium
Ann. Thorac. Surg.,
June 1, 1999;
67(6):
1714 - 1720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. Hughes, K. P. Landolfo, J. E. Lowe, R. B. Coleman, and C. L. Donovan
Perioperative morbidity and mortality after transmyocardial laser revascularization: incidence and risk factors for adverse events
J. Am. Coll. Cardiol.,
March 15, 1999;
33(4):
1021 - 1026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. Hughes, J. E. Lowe, A. P. Kypson, J. D. St. Louis, A. M. Pippen, K. G. Peters, R. E. Coleman, T. R. DeGrado, C. L. Donovan, B. H. Annex, et al.
Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia
Ann. Thorac. Surg.,
December 1, 1998;
66(6):
2029 - 2036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Horvath, R. Greene, N. Belkind, B. Kane, D. D. McPherson, and D. A. Fullerton
Left ventricular functional improvement after transmyocardial laser revascularization
Ann. Thorac. Surg.,
September 1, 1998;
66(3):
721 - 725.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|